Headquarters
France
team size
1 - 4
founded
2013
website
https://acticor-biotech.com
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
Offices
France
HQ address
Bâtiment Inserm U1148, Hôpital Bichat secteur Claude Bernard, Paris, 75877, FRA
Email
contact@acticor-biotech.com
description
Acticor Biotech is a biopharmaceutical company, founded in 2013 as a spin-off of Inserm (Paris, France), developing an innovative drug for the treatment in the acute phase of ischemic stroke.

According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 6 million die and another 5 million are permanently disabled.

Stroke is the third cause of death in the world and the first cause of adult acquired disabilities resulting

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats